13F Activity: As Cvs Health Corporation (CVS) Stock Declined, Thrivent Financial For Lutherans Has Trimmed Its Holding by $6.50 Million

13F Activity: As Cvs Health Corporation (CVS) Stock Declined, Thrivent Financial For Lutherans Has Trimmed Its Holding by $6.50 Million

Thrivent Financial For Lutherans decreased its stake in Cvs Health Corporation (CVS) by 2.92% based on its latest 2016Q3 regulatory filing with the SEC. Thrivent Financial For Lutherans sold 73,895 shares as the company’s stock declined 6.33% while stock markets rallied. The institutional investor held 2.45 million shares of the medical and nursing services company at the end of 2016Q3, valued at $218.38 million, down from 2.53 million at the end of the previous reported quarter. Thrivent Financial For Lutherans who had been investing in Cvs Health Corporation for a number of months, seems to be less bullish one the $89.25B market cap company. The stock is up 0.05% or $0.04 hitting $82.71, despite the negative news. About 5.10M shares traded hands. CVS Health Corp (NYSE:CVS) has declined 14.44% since June 7, 2016 and is downtrending. It has underperformed by 21.86% the S&P500.

Thrivent Financial For Lutherans, which manages about $82.94B and $21.92B US Long portfolio, upped its stake in Whirlpool Corp (NYSE:WHR) by 238,824 shares to 246,777 shares, valued at $40.02 million in 2016Q3, according to the filing. It also increased its holding in Saia Inc (NASDAQ:SAIA) by 259,480 shares in the quarter, for a total of 395,250 shares, and has risen its stake in Mdu Resources Group Inc (NYSE:MDU).

Thrivent Financial For Lutherans is a Minnesota-based institutional investor with more than $82.94 billion AUM in January, 2015. This fund invests only a small percentage of its assets in equities and options. Thrivent Financial For Lutherans is the 63th largest institutional investor in our database. Taken from Thrivent Financial For latest Adv, the fund reported to have 2308 full and part-time employees. Among which 283 performing investment advisory and research functions. The institutional investor had between 26-100 clients.

Insitutional Activity: The institutional sentiment decreased to 0.98 in Q3 2016. Its down 0.02, from 1 in 2016Q2. The ratio is negative, as 74 funds sold all CVS shares owned while 576 reduced positions. 114 funds bought stakes while 525 increased positions. They now own 836.58 million shares or 0.35% more from 833.68 million shares in 2016Q2. Bsw Wealth Prtn holds 0% or 268 shares in its portfolio. Prentiss Smith & Incorporated last reported 3.14% of its portfolio in the stock. Baskin Financial accumulated 89,083 shares or 2.08% of the stock. Manchester Management Ltd Liability Corporation owns 3,761 shares or 0.05% of their US portfolio. Moreover, National Inv Serv Wi has 2.19% invested in CVS Health Corp (NYSE:CVS) for 21,811 shares. Moreover, Barrington Strategic Wealth Mngmt Group Llc has 0.88% invested in CVS Health Corp (NYSE:CVS) for 17,548 shares. First American Fincl Bank has 0.79% invested in the company for 96,507 shares. State Street Corp accumulated 0.36% or 31.76M shares. Wms Partners Limited Co last reported 0.13% of its portfolio in the stock. Guyasuta Investment Advsrs holds 0.24% or 21,061 shares in its portfolio. Driehaus Capital Mgmt Lc has invested 0.05% of its portfolio in CVS Health Corp (NYSE:CVS). Rmb Limited Liability reported 184,594 shares or 0.39% of all its holdings. The California-based Covington Capital Management has invested 1.13% in CVS Health Corp (NYSE:CVS). Veritable Lp accumulated 38,182 shares or 0.09% of the stock. Alpha Cubed Investments Lc holds 0.16% or 6,547 shares in its portfolio.

Analysts await CVS Health Corp (NYSE:CVS) to report earnings on February, 14. They expect $1.67 earnings per share, up 9.15% or $0.14 from last year’s $1.53 per share. CVS’s profit will be $1.80 billion for 12.38 P/E if the $1.67 EPS becomes a reality. After $1.64 actual earnings per share reported by CVS Health Corp for the previous quarter, Wall Street now forecasts 1.83% EPS growth.

More notable recent CVS Health Corp (NYSE:CVS) news were published by: Fool.com which released: “Better Buy: CVS Health Corp. vs. Wal-Mart Stores, Inc.” on December 20, 2016, also Fool.com with their article: “CVS Health Corporation’s Biggest Mistake in 2016” published on December 14, 2016, Fool.com published: “Will 2017 Be CVS Health Corporation’s Worst Year Yet?” on December 21, 2016. More interesting news about CVS Health Corp (NYSE:CVS) were released by: Prnewswire.com and their article: “CVS Health To Present At The 35th Annual J.P. Morgan Healthcare Conference” published on December 30, 2016 as well as Seekingalpha.com‘s news article titled: “CVS Health Corp. – Well, That Hurts” with publication date: December 15, 2016.

According to Zacks Investment Research, “CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, and Novologix names. CVS Health Corporation, formerly known as CVS Caremark Corporation, is headquartered in Woonsocket, Rhode Island.”

CVS Health Corp (NYSE:CVS) Ratings Coverage

Out of 15 analysts covering CVS Health (NYSE:CVS), 10 rate it a “Buy”, 0 “Sell”, while 5 “Hold”. This means 67% are positive. CVS Health has been the topic of 24 analyst reports since July 22, 2015 according to StockzIntelligence Inc. As per Monday, November 2, the company rating was maintained by JP Morgan. The company was maintained on Thursday, December 17 by Oppenheimer. The firm has “Overweight” rating by Barclays Capital given on Friday, December 18. The firm has “Hold” rating given on Wednesday, July 22 by Deutsche Bank. On Wednesday, August 19 the stock rating was reinitiated by Evercore with “Buy”. Goldman Sachs downgraded the shares of CVS in a report on Thursday, December 17 to “Neutral” rating. Deutsche Bank maintained CVS Health Corp (NYSE:CVS) on Thursday, August 20 with “Hold” rating. As per Monday, November 2, the company rating was maintained by S&P Research. As per Wednesday, November 9, the company rating was maintained by Mizuho. The rating was maintained by Oppenheimer on Monday, November 2 with “Outperform”.

CVS Company Profile

CVS Health Corporation, incorporated on August 22, 1996, together with its subsidiaries (CVS Health), is a pharmacy company. The Firm operates through three business divisions: Pharmacy Services, Retail/LTC and Corporate. The Firm offers a range of services and products, such as advising patients on their medications at its CVS Pharmacy locations, introducing programs to help control costs for its clients at CVS Caremark, how care is delivered to its patients with conditions through CVS Specialty, pharmacy care for the senior community through Omnicare. The Pharmacy Services Segment provides a range of pharmacy benefit management (PBM) solutions. The Retail Pharmacy segment includes retail drugstores, online retail pharmacy Websites and its retail healthcare clinics.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Tags: , ,

Leave a Reply

Be the First to Comment!

Notify of